Clinical experience of marketed levetiracetam in an epilepsy clinic — A one year follow up study

Seizure

Volumn 12, Issue 3, 2003, Pages 136-140

  Betts, Tim ^a   Yarrow, Helen ^a   Greenhill, Lyn ^a   Barrett, Mary ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Audit; Levetiracetam; Retention rate; Seizure freedom; Side Effects

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE; ETIRACETAM; LAMOTRIGINE; PIRACETAM; PLACEBO; VALPROIC ACID;

AGGRESSION; ARTICLE; ATAXIA; BEHAVIOR DISORDER; BODY WEIGHT DISORDER; CONTROLLED STUDY; DEPRESSION; DISEASE EXACERBATION; DRUG ABSORPTION; DRUG CHOICE; DRUG EFFICACY; DRUG HALF LIFE; EPILEPSY; FATIGUE; FOCAL EPILEPSY; FOLLOW UP; GENERALIZED EPILEPSY; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MEMORY DISORDER; MONOTHERAPY; NAUSEA; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0037390579     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1059-1311(02)00258-3     Document Type: Article

References (9)

1. Kwan, P. and Brodie, M. Early identification of refractory epilepsy. New England Journal of Medicine 2000; 342: 314-319.
2. Kwan, P. and Brodie, M. Refractory epilepsy: a progressive, intractable but preventable condition? Seizure 2002; 11: 77-84.
3. Klitgaard, H., Matagne, A., Gobert, J. and Wulfert, E. Evidence for a unique profile of Levetiracetam in rodent models of seizures and epilepsy. European Journal of Pharmacology 1998; 353: 191-206.
4. Noyer, M. The novel antiepileptic drug Levetiracetam (UCB 2059) appears to act via a specific binding site in CN5 membranes. European Journal of Pharmacology 1995; 286: 137-146.
5. Patsalos, P. Pharmacological profile of Levetiracetam: towards ideal characteristics. Pharmacology and Therapeutics 2000; 85: 77-85.
6. Ceringho, J., Biton, V., Abou-Khalil, B. et al. Levetiracetam for partial seizures: result of a double blind, randomised clinical trial. Neurology 2000; 55: 236-242.
7. Krakow, K., Walker, M., Otoul, C. and Sander, J. Long-term continuation of Levetiracetam in patients with refractory epilepsy. Neurology 2001; 56: 1772-1774.
8. Greenhill, L., Betts, T., and Yarrow, H. Effect of Levetiracetam on resistant Juvenile Myoclonic Epilepsy. Seizure 2002; 11, to be published.
9. Betts, T. and Greenhill, L. Effect of Levetiracetam on photo paroxysmal responses in the EEG. Seizure 2002; 11, to be published.